Brief: Abionyx H1 Operating Loss Narrows To EUR 2.2 Mln
Sept 27 - Abionyx Pharma SA ABNX.PA :
* REPORTED ON TUESDAY H1 REVENUES EUR 2.1 MLN VS EUR 2.6 MLN
YR
AGO
* H1 OPERATING LOSS EUR 2.2 MLN VS LOSS EUR 2.5 MLN YR AGO
* H1 NET LOSS EUR 2.3 MLN VS LOSS EUR 2.6 MLN YR AGO
Source text for Eikon: urn:newsml:reuters.com:*:nBw4X1XgSa
Further company coverage: ABNX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls